Skip to content

NADISOINS INFIRMIERS

Active
Private limited companyfounded 201214 yrs activeRue Roulez(GY) 4, 6181 Courcelles, BelgiumKBO/BCE: BE 0842.611.779
Summary

NADISOINS INFIRMIERS has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €14k and a net result of €25k. Equity remains stable across the filed fiscal years (±0% per year). The computed 12-month bankruptcy probability is 1.1% (low).

Checked score

Score 2025
79 / 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency88▲+11
Growth58=
Track record100
Bankruptcy probability, 12 months
1.1% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €1k at 30 days acceptable
Liquidity ample (current ratio 2.67 against 2.07 in 2024; short-term debt: 37.3% and cash: 21.5% of total assets), and 37.3% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 14 years 0 20 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
62.7%
Return on assets
111.2%
Age of the figures
9 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €14k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
1 d early
2024
on the day
2023
2 d late
2022
32 d early
2021
11 d late
2020
1 d early
2019
1 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€14k▲ 17.7%
2024 · €12k
2018: €17k 2019: €8k 2020: €8k 2021: €8k 2022: €8k 2023: €8k 2024: €12k
2018 → 2025
Total assets
€22k▼ 2.8%
2024 · €23k
2018: €30k 2019: €38k 2020: €35k 2021: €18k 2022: €22k 2023: €24k 2024: €23k
2018 → 2025
Net result
€25k▼ 0.3%
2024 · €25k
2018: €15k 2019: €16k 2020: €20k 2021: €15k 2022: €21k 2023: €22k 2024: €25k
2018 → 2025
Working capital
€14k▲ 17.9%
2024 · €12k
2018: €256 2019: €-4k 2020: €2k 2021: €7k 2022: €8k 2023: €8k 2024: €12k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€8k-€8k=€8k=€12k▲ 47.4%€14k▲ 17.7%
Operating result€23k-€31k▲ 33.5%€32k▲ 2.1%€34k▲ 8.8%€34k▲ 0.2%
Net result€15k-€21k▲ 39.8%€22k▲ 5.2%€25k▲ 12.3%€25k▼ 0.3%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€10k€20k€30kOperating result 2021: €23k€23kNet result 2021: €15k€15kOperating result 2022: €31k€31kNet result 2022: €21k€21kOperating result 2023: €32k€32kNet result 2023: €22k€22kOperating result 2024: €34k€34kNet result 2024: €25k€25kOperating result 2025: €34k€34kNet result 2025: €25k€25k20212022202320242025€0€10k€20k€30kOperating result 2023: €32k€32kNet result 2023: €22k€22kOperating result 2024: €34k€34kNet result 2024: €25k€25kOperating result 2025: €34k€34kNet result 2025: €25k€25k202320242025
The operating result has risen four years in a row; 2025 is 0% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €22k
Fixed assets €95 =
Current assets €22k ▼ 2.8%
Equity and liabilities €22k
Equity €14k ▲ 17.7%
Debt €8k ▼ 24.8%
Debt's share of the balance-sheet total falls from 48.2% to 37.3%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
Current ratio
2.67
2024 · 2.07
Debt to equity
0.60
2024 · 0.93
ROE
177.4%
2024 · 209.5%
ROA
111.2%
2024 · 108.5%
Debt ≤ 1 year
€8k
2024 · €11k
Income taxes
€9k
2024 · €9k
Staff costs
€9
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 40 lines
Balance sheet Code20242025
Assets
Total assets20/58€23k€22k
Fixed assets21/28€95€95=
Financial fixed assets28€95€95=
Current assets29/58€23k€22k
Amounts receivable within one year40/41€10k€12k
Trade receivables40€180-
Other amounts receivable41€10k€12k
Cash at bank and in hand54/58€8k€5k
Deferred charges and accrued income490/1€5k€5k
Equity and liabilities
Total equity and liabilities10/49€23k€22k
Equity10/15€12k€14k
Contributions10/11€6k€6k=
Reserves13€6k€8k
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€4k€6k
Amounts payable17/49€11k€8k
Amounts payable within one year42/48€11k€8k
Trade debts44-€22
Suppliers440/4-€22
Taxes, remuneration and social security45€11k€8k
Taxes450/3€11k€8k
Income statement Code20242025
Remuneration, social security and pensions62-€9
Other operating charges640/8€801€695
Gross operating margin9900€35k€35k
Operating profit (loss)9901€34k€34k
Financial income75/76B-€3
Recurring financial income75-€3
Financial charges65/66B€566€765
Recurring financial charges65€566€765
Profit (loss) for the period before taxes9903€34k€34k
Income taxes67/77€9k€9k
Profit (loss) for the period9904€25k€25k
Profit (loss) for the period to be appropriated9905€25k€25k
Appropriation of the result
Profit (loss) to be appropriated9906€25k€25k
Transfer from equity791/2-€23k
Transfer to equity691/2€4k€25k
To other reserves6921€4k€25k
Profit to be distributed694/7€21k€23k
Return on contributions (dividend)694€21k€23k

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
30-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Highest result since 2018net €25k ▲12.3%
Net result €25k, the highest in the series.
02-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 2 days late
2023
29-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
11-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 11 days late
2021
31-12
Financial Weakest financial yearnet €15k ▼23.7%
Net result drops to €15k, the lowest in the series; recovery starts the following year.
30-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
30-07
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
03-07
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
31-07
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
04-08
NBB filing Annual accounts filed
fiscal year 2016 · full schema · 4 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Courcelles · 1 establishment unit since 2012
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Rue Roulez(GY) 46181 Courcelles
Ground area
1,009 m²
Building footprint
158 m²
2 parcels, Wallonia. Linked by address, not a title deed.
1 establishment unit
NADISOINS INFIRMIERS
Rue Chantraine(PAC) 4A, 6230 Pont-à-CellesHuman health activities
since 20122.206.997.448
2 parcels
Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
52055D0565/00L026 Wallonia 806 m² 1 · 119 m² -
52031B0937/00Z000 Wallonia 204 m² 1 · 39 m² -
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded11-01-2012
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.